Literature DB >> 966060

Scintigraphic detection of hepatic metastases with 131I-labeled steroid in recurrent adrenal carcinoma: case report.

K Watanabe, I Kamoi, C Nakayama, I Koga, K Matsuura.   

Abstract

Abdominal scintigraphy using a new 131I-labeled steroid agent was performed on a 40-year-old women proven by surgery to have adrenocortical carcinoma. Considerable accumulations were observed at the sites of liver metastasis. Hepatic scintigraphy and autopsy findings revealed that the accumulation was more marked on the active cancer cells and only slight in the central necrotic tissue. Adrenal scintigraphy is valuable in the study of metastatic hormone-producing adrenal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 966060

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Radioiodocholesterol scintigraphy in adrenal gland tumors.

Authors:  L Troncone
Journal:  Eur J Nucl Med       Date:  1980-08

2.  Uptake of 75Se-selenocholesterol by an adrenal cortical carcinoma and its metastases.

Authors:  E Reschini; M Peracchi
Journal:  Eur J Nucl Med       Date:  1984

3.  The scintigraphic localization of mineralocorticoid-producing adrenocortical carcinoma.

Authors:  Y Shenker; M D Gross; R J Grekin; S G Rosen; J A Sanfield; B Shapiro; B Samuels; W Strodel; N W Thompson; T F Beals
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

4.  Imaging findings of pelvic tumor thrombosis extending from sacral bone metastasis of adrenocortical carcinoma.

Authors:  Kenichiro Ishida; Yusuke Inoue; Reiko Woodhams; Yuji Asano; Toshimasa Hara
Journal:  Case Rep Radiol       Date:  2012-12-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.